In cases where you might need usage of a medically-important drug for a significant or existence-threatening situation where there is no sector approved drug obtainable in copyright and for which option common therapies have unsuccessful or are unsuitable, Overall health copyright's Distinctive Access Programme (SAP) is on the market that can help